Graft versus host disease: New insights into A 2A receptor agonist therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Graft versus host disease: New insights into A 2A receptor agonist therapy

Published:2015 Issue: Volume:13 Page:101-105
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Jones Karlie R.,Kang Elizabeth M.

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference50 articles.

1. Prevention and treatment of acute GvHD;Messina;Bone Marrow Transplant,2008

2. Adenosine A(2)A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease;Han;J Immunol,2013

3. Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation;Lappas;J Leukoc Biol,2010

4. Acute graft versus host disease;Jacobsohn;Orphanet J Rare Dis,2007

5. Steroid-refractory acute GVHD: predictors and outcomes;Westin;Adv Hematol,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods for Testing Immunological Factors;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

2. Histamine H3R antagonist counteracts the impaired hippocampal neurogenesis in Lipopolysaccharide-induced neuroinflammation;International Immunopharmacology;2022-09

3. Adenosine-A2A Receptor Pathway in Cancer Immunotherapy;Frontiers in Immunology;2022-03-21

4. Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway;International Journal of Biological Macromolecules;2019-07

5. Regulation of the Immune Response by the Inflammatory Metabolic Microenvironment in the Context of Allotransplantation;Frontiers in Immunology;2018-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3